Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

Scedosporium species and Lomentospora prolificans (S/L) are the second most common causes of invasive mold infections following Aspergillus in lung transplant recipients.

[1]  S. Ranque,et al.  Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis. , 2018, Medical mycology.

[2]  S. Ranque,et al.  Scedosporium and Lomentospora: an updated overview of underrated opportunists. , 2018, Medical mycology.

[3]  N. Mueller,et al.  A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature , 2018, Transplant infectious disease : an official journal of the Transplantation Society.

[4]  S. Leroy,et al.  Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study , 2018, Mycopathologia.

[5]  R. Guillemain,et al.  Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single‐center 15‐year experience , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[6]  M. Slater,et al.  F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase , 2016, Proceedings of the National Academy of Sciences.

[7]  P. Carver,et al.  Antifungal Prophylaxis in Lung Transplant Recipients , 2016, Transplantation.

[8]  M. Paraskeva,et al.  Invasive Scedosporium sternal osteomyelitis following lung transplant: Cured , 2016, Medical mycology case reports.

[9]  A. Zaas,et al.  The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  G. S. de Hoog,et al.  The 'species complex' issue in clinically relevant fungi: A case study in Scedosporium apiospermum. , 2016, Fungal biology.

[11]  S. Peter,et al.  Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[12]  Steven He,et al.  Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey , 2015, Transplant infectious disease : an official journal of the Transplantation Society.

[13]  P. Reix,et al.  Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[14]  K. Thursky,et al.  Disseminated Scedosporium prolificans infection in an ‘extensive metaboliser’: navigating the minefield of drug interactions and pharmacogenomics , 2014, Mycoses.

[15]  V. Havlíček,et al.  Proposed nomenclature for Pseudallescheria, Scedosporium and related genera , 2014, Fungal Diversity.

[16]  B. Alexander,et al.  Epidemiology of Invasive Mold Infections in Lung Transplant Recipients , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  L. Pagano,et al.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  A. Bernhardt,et al.  Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[19]  T. Sorrell,et al.  In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. , 2013, The Journal of antimicrobial chemotherapy.

[20]  G. Hansen,et al.  Successful prevention of scedosporiosis after lung transplantation in a cystic fibrosis patient by combined local and systemic triazole therapy , 2013, Medical mycology case reports.

[21]  G. Feierl,et al.  Modified culture method detects a high diversity of fungal species in cystic fibrosis patients. , 2013, Medical mycology.

[22]  B. Schwartz,et al.  Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[23]  J. Pilewski,et al.  Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity , 2012, Antimicrobial Agents and Chemotherapy.

[24]  J. Meis,et al.  Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species , 2012, Antimicrobial Agents and Chemotherapy.

[25]  P. D. de Jong,et al.  Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum , 2011, Case reports in infectious diseases.

[26]  A. Reisman,et al.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis , 2011, Infection.

[27]  M. Hannan,et al.  A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients , 2011, The Journal of Heart and Lung Transplantation.

[28]  G. Snell,et al.  Antifungal Prophylaxis in Lung Transplantation—A World‐wide Survey , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  P. Burgel,et al.  Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. , 2010, Medical mycology.

[30]  S. Ranque,et al.  Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. , 2010, Medical mycology.

[31]  M. Montagna,et al.  Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis. , 2010, Medical mycology.

[32]  E. Anaissie,et al.  Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients , 2010, Transplant infectious disease : an official journal of the Transplantation Society.

[33]  E. Anaissie,et al.  Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  P. Le Pape,et al.  Disseminated Scedosporium/Pseudallescheria Infection after Double-Lung Transplantation in Patients with Cystic Fibrosis , 2010, Journal of Clinical Microbiology.

[35]  S. Yousem,et al.  Impact of Mold Infections in Explanted Lungs on Outcomes of Lung Transplantation , 2010, Transplantation.

[36]  O. Lee,et al.  Detection of Occult Scedosporium Species in Respiratory Tract Specimens from Patients with Cystic Fibrosis by Use of Selective Media , 2009, Journal of Clinical Microbiology.

[37]  T. Sorrell,et al.  Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38]  L. Delhaes,et al.  Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. , 2009, Medical mycology.

[39]  T. Sorrell,et al.  Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  G. S. de Hoog,et al.  A review of German Scedosporium prolificans cases from 1993 to 2007. , 2009, Medical mycology.

[41]  G. Marklein,et al.  Isolation and clinical significance of Pseudallescheria and Scedosporium species. , 2009, Medical mycology.

[42]  T. Mohammed,et al.  Pseudallescheria boydii (Scedosporium species) in 3 Lung Transplant Recipients: Computed Tomography Findings and Literature Review , 2009, Journal of computer assisted tomography.

[43]  R. Siekmeier,et al.  Selective Isolation of Pseudallescheria and Scedosporium Species from Respiratory Tract Specimens of Cystic Fibrosis Patients , 2008, Respiration.

[44]  D. Ellis,et al.  Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients , 2008, Antimicrobial Agents and Chemotherapy.

[45]  Karin Thursky,et al.  Infection with Scedosporium apiospermum and S. prolificans, Australia , 2007, Emerging infectious diseases.

[46]  A. Mehta,et al.  Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[47]  D. Pakstis,et al.  Voriconazole Prophylaxis in Lung Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  D. Paterson,et al.  Variation in antifungal prophylaxis strategies in lung transplantation , 2006, Transplant infectious disease : an official journal of the Transplantation Society.

[49]  M. Estenne,et al.  Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  J. Duncan,et al.  Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. , 2005, American journal of ophthalmology.

[51]  J. Fung,et al.  Pseudallescheria boydii (Anamorph Scedosporium apiospermum) Infection in Solid Organ Transplant Recipients in a Tertiary Medical Center and Review of the Literature , 2002, Medicine.

[52]  M. Diouri,et al.  Genotyping Study of Scedosporium apiospermum Isolates from Patients with Cystic Fibrosis , 2002, Journal of Clinical Microbiology.

[53]  M. Tamm,et al.  Pulmonary scedosporium infection following lung transplantation , 2001, Transplant infectious disease : an official journal of the Transplantation Society.

[54]  D. Speers,et al.  Molecular Epidemiology of Scedosporium apiospermum Infection Determined by PCR Amplification of Ribosomal Intergenic Spacer Sequences in Patients with Chronic Lung Disease , 2001, Journal of Clinical Microbiology.

[55]  P. Sweny.  Infection in solid organ transplant recipients , 1989 .

[56]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[57]  J. Weinkauf,et al.  Case report of vertebral osteomyelitis and mycotic abdominal aortic aneurysm caused by Scedosporium apiospermum in a lung transplant patient with cystic fibrosis. , 2015, Transplantation proceedings.

[58]  T. Haddad,et al.  Management of Scedosporium apiospermum in a pre- and post-lung transplant patient with cystic fibrosis. , 2013, Medical mycology case reports.

[59]  G. Raghu,et al.  American Thoracic Society Documents An Official American Thoracic Society Clinical Practice Guideline : The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease , 2012 .

[60]  Nina Singh,et al.  Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  J. Bouchara,et al.  Clinical Significance of Scedosporium apiospermum in Patients with Cystic Fibrosis , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[62]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .